Screening for toxoplasmosis in pregnancy: what is the evidence of reducing a health problem?
- PMID: 9041483
- DOI: 10.1177/096914139600300406
Screening for toxoplasmosis in pregnancy: what is the evidence of reducing a health problem?
Abstract
Objectives: Toxoplasma gondii is a parasite which may give rise to congenital infection. Screening pregnant women for antibodies against toxoplasmosis is being debated in many countries. The preventive impact of toxoplasmosis screening of pregnant women depends on the magnitude of disease caused by congenital toxoplasmosis (incidence x transmission rate to fetus x diseased proportion of infected children), on the one hand, and the preventable proportion of disease (sensitivity of the screening test x efficacy of the treatment x compliance), on the other. In this study the preventive impact of screening pregnant women for toxoplasmosis antibodies is assessed by letting the value for these variables change within reasonable limits.
Methods: To obtain information on these variables, relevant publications were reviewed in the Medline database from 1983 to February 1996 and the Cochrane Pregnancy and Childbirth Database. References in review articles on congenital toxoplasmosis were also studied.
Results: The literature review showed that no population based prospective studies of the natural history of toxoplasmosis infection during pregnancy, nor any randomised controlled trials of the efficacy of antiparasitic treatment, had been carried out. In the empirical studies which have been performed the values of most variables show considerable differences. According to these values, the estimates in this study of the impact of toxoplasmosis screening in pregnancy may range from 0 to 40 children in whom disease is preventable per 100,000 pregnant women susceptible to toxoplasmosis infection.
Conclusion: Sufficient scientific evidence is not yet available to propose screening for toxoplasmosis in pregnant women, and efforts should be made to provide such knowledge. Also, the magnitude of the negative impact of screening, such as induced abortion of healthy fetuses, anxiety in women with false positive screening tests, and side effects of treatment, has not been sufficiently examined.
Similar articles
-
Congenital toxoplasmosis: is screening desirable?Scand J Infect Dis Suppl. 1992;84:11-7. Scand J Infect Dis Suppl. 1992. PMID: 1290068 Review.
-
Diagnosis and management of toxoplasmosis.Clin Perinatol. 2005 Sep;32(3):705-26. doi: 10.1016/j.clp.2005.04.011. Clin Perinatol. 2005. PMID: 16085028 Review.
-
Prevention of congenital toxoplasmosis in Slovenia by serological screening of pregnant women.Scand J Infect Dis. 2002;34(3):201-4. doi: 10.1080/00365540110080386. Scand J Infect Dis. 2002. PMID: 12030394
-
[Toxoplasmosis--epidemiology, clinical manifestation and infection in pregnant women].Przegl Lek. 2006;63(2):97-9. Przegl Lek. 2006. PMID: 16969908 Review. Polish.
-
Toxoplasmosis in pregnancy: prevention, screening, and treatment.J Obstet Gynaecol Can. 2013 Jan;35(1):78-81. doi: 10.1016/s1701-2163(15)31053-7. J Obstet Gynaecol Can. 2013. PMID: 23343802 English, French.
Cited by
-
Value of prenatal diagnosis and early postnatal diagnosis of congenital toxoplasmosis: retrospective study of 110 cases.J Clin Microbiol. 1999 Sep;37(9):2893-8. doi: 10.1128/JCM.37.9.2893-2898.1999. J Clin Microbiol. 1999. PMID: 10449471 Free PMC article.
-
Spiramycin/cotrimoxazole versus pyrimethamine/sulfonamide and spiramycin alone for the treatment of toxoplasmosis in pregnancy.J Perinatol. 2015 Feb;35(2):90-4. doi: 10.1038/jp.2014.161. Epub 2014 Sep 11. J Perinatol. 2015. PMID: 25211284
-
Congenital toxoplasmosis.BMJ Clin Evid. 2008 Mar 27;2008:0906. BMJ Clin Evid. 2008. PMID: 19450322 Free PMC article.
-
Toxoplasmosis, cytomegalovirus, listeriosis, and preconception care.Matern Child Health J. 2006 Sep;10(5 Suppl):S187-91. doi: 10.1007/s10995-006-0092-0. Matern Child Health J. 2006. PMID: 16752091 Free PMC article. No abstract available.
-
Newborn screening for congenital infectious diseases.Emerg Infect Dis. 2004 Jun;10(6):1068-73. doi: 10.3201/eid1006.030830. Emerg Infect Dis. 2004. PMID: 15207059 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical